![Spyridon Papapetropoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Spyridon Papapetropoulos
Gründer bei
Encephalos Life Sciences LLC
Vermögen: 230 641 $ am 31.05.2026
Profil
Spyridon Papapetropoulos is the founder of Encephalos Life Sciences LLC.
Dr. Papapetropoulos is President, Chief Executive Officer & Director at Bionomics Ltd. since 2023.
Dr. Papapetropoulos is Chief Executive Officer & Executive Director at Neuphoria Therapeutics, Inc. starting in 2024.
Former roles include Chief Executive Officer at SwanBio Therapeutics, Inc. from 2019 to 2020; Chairman at Lipocine, Inc. from 2022 to 2026; Independent Director at Adamas Pharmaceuticals LLC from 2020 to 2021; Chief Development Officer, SVP & Head-Development at ACADIA Pharmaceuticals, Inc. from 2019 to 2020; Chief Medical Officer & EVP-R&D at Cavion, Inc. from 2017 to 2019; and Chief Medical Officer at Vigil Neuroscience, Inc. from 2020 to 2023.
Education includes doctorates from the University of Patras and Semmelweis University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.32% | 16.04.2025 | 5’999’940 ( 0.32% ) | 175 258 $ | 31.05.2026 |
0.18% | 29.09.2025 | 9’888 ( 0.18% ) | 52 505 $ | 31.05.2026 |
LIPOCINE INC 0.02% | 04.06.2025 | 1’279 ( 0.02% ) | 2 878 $ | 31.05.2026 |
Aktive Positionen von Spyridon Papapetropoulos
| Unternehmen | Position | Beginn |
|---|---|---|
Encephalos Life Sciences LLC
 Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Gründer | - |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Vorstandsvorsitzender | 05.01.2023 |
Ehemalige bekannte Positionen von Spyridon Papapetropoulos
| Unternehmen | Position | Ende |
|---|---|---|
| LIPOCINE INC. | Vorsitzender | 16.04.2026 |
| VIGIL NEUROSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.01.2023 |
| ADAMAS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 24.11.2021 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Vorstandsvorsitzender | 01.10.2020 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.09.2020 |
Ausbildung von Spyridon Papapetropoulos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Patras
 University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semmelweis University
 Semmelweis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
 Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Commercial Services |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
